Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Glioneuronal tumours are an increasingly recognized cause of chronic pharmaco‐resistant epilepsy. In the present study the immunocytochemical expression of various glutamate receptor (GluR) subtypes was investigated in 41 gangliogliomas (GG) and 16 dysembryoplastic neuroepithelial tumours (DNT) from patients with intractable epilepsy. Immunocytochemistry with antibodies specific for ionotropic NR1, NR2A/B (NMDA) GluR1, GluR2 (AMPA), GluR5–7 (kainate), and metabotropic mGluR1, mGluR2–3, mGluR5, mGluR7a subtypes demonstrated in both GG and DNT the presence of an highly differentiated neuronal population, containing subunits from each receptor class. More than 50% of tumours contained a high percentage of neuronal cells immunolabelled for NMDA, AMPA and kainate receptor subunits. A high percentage of neurones showed strong expression of NR2A–B, which co‐localized with NR1. Group I mGluRs (mGluR1 and mGluR5) were highly represented in the neuronal component of the tumours. Immunolabelling for several GluRs was also present in the glial component. Increased expression of mGluR2–3, mGluR5 and GluR5–7 was observed in reactive astrocytes in the perilesional zone compared to normal cortex. The neurochemical profile of glioneuronal tumours, with high expression of specific GluR subtypes, supports the central role of glutamatergic transmission in the mechanisms underlying the intrinsic and high epileptogenicity of these lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular diversity of glutamate receptors and implications for brain function
Nakanishi, S. (1992) · Science · doi:10.1126/science.1329206 · Cited by 2,543
Heteromeric NMDA receptors: molecular and functional distinction of subtypes
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541
Cited by
Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management
van Breemen, M. S., Wilms, E. B., & Vecht, C. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70103-5 · Cited by 913
Gangliogliomas: An Intriguing Tumor Entity Associated With Focal Epilepsies
Blümcke, I., & Wiestler, O. D. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.7.575 · Cited by 378
Aronica, E., Gorter, J. A., Ijlst‐Keizers, H., Rozemuller, A. J., Yankaya, B., Leenstra, S., & Troost, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02657.x · Cited by 305
Self-citationSeizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments
Ruda, R., Bello, L., Duffau, H., & Soffietti, R. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos199 · Cited by 280
Astrocytes in the initiation and progression of epilepsy
Vezzani, A., Ravizza, T., Bedner, P., Aronica, E., Steinhäuser, C., & Boison, D. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00727-5 · Cited by 272
Self-citation
Metadata
- Authors
- Aronica, E., Yankaya, B., Jansen, G. H., Leenstra, S., Van Veelen, C. W. M., Gorter, J. A., & Troost, D.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2001-06
- Volume
- 27
- Issue
- 3
- Pages
- 223-237
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W2152516757
- Cited by
- 147
- References
- 2
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy. https://app.cochat.ai/papers/10.1046/j.0305-1846.2001.00314.x
- The paper
- Aronica, E., Yankaya, B., Jansen, G. H., Leenstra, S., Van Veelen, C. W. M., Gorter, J. A., & Troost, D. (2001). Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy. Neuropathology and Applied Neurobiology. https://doi.org/10.1046/j.0305-1846.2001.00314.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.